MLTX

MoonLake Immunotherapeutics$19.03+0.65 (+3.54%)

Prev Close$18.38·MCap$1.52B·P/E—·Vol455.8K·Yield—

▲

Buys (12M)

$98.8K

▼

Sells (12M)

$50.89M

◆

Net Activity

Net Seller

$50.80M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at MoonLake Immunotherapeutics (MLTX) has been dominated by selling, with 1 insider purchase totaling $98.8K and 3 insider sales totaling $50.89M. The most recent insider transaction was by Santos da Silva Jorge (Chief Executive Officer), who sold $2.97M worth of shares on Dec 8, 2025. MoonLake Immunotherapeutics operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.52B.

MLTX Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value
Dec 8, 2025	Santos da Silva Jorge	Chief Executive Officer	Sell	200,000	$14.87	$2.97M
Dec 8, 2025	Reich Kristian	Chief Scientific Officer	Sell	72,908	$14.43	$1.05M
Oct 8, 2025	Bodenstedt Matthias	Chief Financial Officer	Buy	10,870	$9.09	$98.8K
Sep 29, 2025	Chen Bihua	Insider	Sell	6,499,978	$7.21	$46.87M9.1% OS
Jul 3, 2025	Moukheibir Catherine	Director	Sell	23,500	$48.79	$1.15M

MLTX Insider Buying Activity

The following table shows recent insider purchases of MoonLake Immunotherapeutics (MLTX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Oct 8, 2025	Bodenstedt Matthias	Chief Financial Officer	Buy	10,870	$9.09	$98.8K	0

MLTX Insider Selling Activity

The following table shows recent insider sales of MoonLake Immunotherapeutics (MLTX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Dec 8, 2025	Santos da Silva Jorge	Chief Executive Officer	Sell	200,000	$14.87	$2.97M
Dec 8, 2025	Reich Kristian	Chief Scientific Officer	Sell	72,908	$14.43	$1.05M
Sep 29, 2025	Chen Bihua	Insider	Sell	6,499,978	$7.21	$46.87M9.1% OS
Jul 3, 2025	Moukheibir Catherine	Director	Sell	23,500	$48.79	$1.15M